Aesculap Biologics

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Aesculap Biologics sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting later-stage tilt upper half by trial count

Aesculap Biologics: 2 sponsored US clinical trials, none currently recruiting.

Aesculap Biologics sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Articular Cartilage of the Femoral Condyle Between 2-6cm2, with 1 trials.

Mid-pack sponsor footprint

Aesculap Biologics is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Aesculap Biologics archive is shaped

2 indexed studies, none listed as recruiting (0% open).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Articular Cartilage of the Femoral Condyle Between 2-6cm2 (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Aesculap Biologics: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Aesculap Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Aesculap Biologics1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Aesculap Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Aesculap Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Aesculap Biologics page

2 registered trials is a research-attention snapshot, not an endorsement of Aesculap Biologics or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Aesculap Biologics pipeline card: 2 registered trials from official public datasets.Report a data error.